Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion type Assertion NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_head.
- NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion description "[We identified individuals with CYP2C9*2 and CYP2C9*3 genotypes (>or=1 variant allele) in the Adenoma Prevention with Celecoxib trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_provenance.
- NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion evidence source_evidence_literature NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_provenance.
- NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion SIO_000772 19233181 NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_provenance.
- NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion wasDerivedFrom befree-20140225 NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_provenance.
- NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_assertion wasGeneratedBy ECO_0000203 NP651907.RA2_YY-J4SbvlEt6N6ncS9lNwbr47ZCjbDpW6zoJ2sSoM130_provenance.